Stock detail

Uniqure (QURE) stock price, chart, and key data

View Uniqure stock price, chart movement, and headline metrics on Woodstock's stock detail page.

QURE

Stock detail

Uniqure

QURE · XNAS

-$3.59 (-9.17%) past day

$35.57

After hours $37.21 (-2.62%)

XNAS24/5 tradingLast updated: Jul 29, 04:01 AM

Key metrics

Earnings

Quarterly results and the next expected release

0.00-0.30-0.60-0.89-1.19
FY2025 Q2Expected EPS: -0.60
FY2025 Q3Expected EPS: -1.19
FY2025 Q4Expected EPS: -0.47
FY2026 Q1Expected EPS: -0.73
FY2026 Q2
FY2026 Q3

FY25 Q2

Q3

Q4

FY26 Q1

Q2

Q3

Reported EPSExpected EPS

Day range

$35.44 - $39.90

52-week range

$8.73 - $71.50

Close price

$38.21

Market cap

$2.7B

P/E ratio

-56

Beta

0.9

About the company

UNIQURE BV

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

Ticker holders

Review politician disclosures and insider transactions in tabs.

No holder data is available for this category yet.

Market action

A concise summary of the latest filing, transaction, or market-moving item.

Latest EDGAR 4 filed on 2026-07-07, report date 2026-07-02: Kapusta Matthew C / uniQure N.V. reports ownership changes; on 07/02/2026; in Ordinary Shares; including 21,082 shares at 19.39 per share; 540,309 shares at 44.43 per share; 9,200 shares at 44.43 per share; 531,109 shares at 45.43 per share; 4,282 shares at 45.43 per share; 526,827 shares at 45.89 per share; 7,600 shares at 45.89 per share; 1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. 2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 5. The Stock Option vested in full on January 26, 2022. /s/ Christian Klemt, Attorney-in-Fact 07/07/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

24/5 Trading

Act on the stock when the timing works for you.

With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.

*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.

Download the app
24/5 trading chart preview

Sign Up

Scan the QR code to get started

Contact via LINE

Scan the QR code to get started

LINE QR Code